Developmental effects of coumarin and the anticoagulant coumarin derivative warfarin on zebrafish (Danio rerio) embryos.

作者: Stefan Weigt , Nicole Huebler , Ruben Strecker , Thomas Braunbeck , Thomas H. Broschard

DOI: 10.1016/J.REPROTOX.2011.07.001

关键词:

摘要: Coumarin and warfarin, two substances which are intensively metabolized in animals humans, were tested for teratogenicity embryo lethality a 3-day vitro assay using zebrafish embryos. Warfarin is coumarin derivative, but contrast to the mother substance warfarin has anticoagulant properties. Both produced teratogenic lethal effects The LC(50) EC(50) values 855 μM 314 μM, respectively; corresponding 988 194 μM. For coumarin, three main or fingerprint endpoints (malformation of head, tail growth retardation) identified, whereas malformation was only endpoint warfarin. analysis ratios between effect concentrations both human therapeutic plasma confirmed potential as well equivocal status coumarin.

参考文章(90)
Roland Nagel, DarT: The embryo test with the Zebrafish Danio rerio--a general model in ecotoxicology and toxicology. ALTEX-Alternatives to Animal Experimentation. pp. 38- 48 ,(2002)
James L. Schardein, Orest T. Macina, Human Developmental Toxicants: Aspects of Toxicology and Chemistry ,(2006)
Roger K. Freeman, Gerald G. Briggs, Sumner J. Yaffe, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk ,(1986)
D Nicoll-Griffith, E G Herold, N Chauret, D H Patrick, J M Drey, S J Grossman, J A Yergey, D R Umbenhauer, D W Alberts, CYP1A1 specificity of Verlukast epoxidation in mice, rats, rhesus monkeys, and humans. Drug Metabolism and Disposition. ,vol. 21, pp. 1029- 1036 ,(1993)
Herbert C. Flessa, Albert B. Kapstrom, Helen I. Glueck, John J. Will, Placental transport of heparin. American Journal of Obstetrics and Gynecology. ,vol. 93, pp. 570- 573 ,(1965) , 10.1016/0002-9378(65)90518-1
James R. Gillette, Herbert Schumacher, Joan M. Gurian, David A. Blake, A comparison of the teratogenic activity of thalidomide in rabbits and rats. Journal of Pharmacology and Experimental Therapeutics. ,vol. 160, pp. 189- 200 ,(1968)
J. Hirsh, J. F. Cade, E. F. O'Sullivan, Clinical Experience with Anticoagulant Therapy During Pregnancy BMJ. ,vol. 1, pp. 270- 273 ,(1970) , 10.1136/BMJ.1.5691.270
Eli Chan, Andrew Mclachlan, Robert O'reilly, Malcolm Rowland, Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model. Clinical Pharmacology & Therapeutics. ,vol. 56, pp. 286- 294 ,(1994) , 10.1038/CLPT.1994.139